Nursing intervention effect of HFMEA mode after hepatocellular carcinoma perfusion embolization intervention
TANG Fen1 XU Xuan1 LIU Huilian1 YU Xiaoxiang2▲
1.Department of Medical Imaging, Qinhuai Medical District, Eastern Theater General Hospital, Jiangsu Province, Nanjing 210002, China;
2.Department of Cardiology, Qinhuai Medical District, Eastern Theater General Hospital, Jiangsu Province, Nanjing 210002, China
Abstract：Objective To explore the nursing intervention effect of healthcare failure mode and effect analysis(HFMEA) mode after hepatocellular carcinoma perfusion embolization intervention. Methods A total of 184 patients with liver cancer who underwent perfusion embolization interventional surgery in Qinhuai Medical District, Eastern Theater Command General Hospital from January 2021 to December 2021 were selected as the study objects. The patients were divided into intervention group and conventional group according to the admission odd-even number, with 92 cases in each group. The intervention group adopted nursing intervention measures based on HFMEA model, and the conventional group adopted routine nursing intervention measures. The changes of cancer-induced fatigue score, quality of life score, serum alpha-fetoprotein (AFP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and C-reactive protein (CRP) before and after intervention were compared between the two groups, and the occurrence of toxic and side effects were compared between the two groups. Results After intervention, somatic fatigue score, emotional fatigue score, cognitive fatigue score, and total cancer-related fatigue score in both groups were lower than before intervention, and those of the intervention group were lower than those of the conventional group (P＜0.05); after intervention, the physical status, social/family status, emotional status, functional status, and total quality of life score in both groups were higher than before intervention, and those of the intervention group were higher than those of the conventional group (P＜0.05). After intervention, the values of AFP, ALT, AST, and CRP in both groups were lower than before intervention (P＜0.05). During embolization chemotherapy, the degree of nausea and vomiting reaction in the intervention group was significantly lower than that in the conventional group, and the difference was statistically significant (P＜0.05). Conclusion The nursing intervention based on HFMEA model can significantly improve the quality of life, reduce the degree of cancer fatigue, and reduce the degree of toxic and side effects after the interventional operation of liver cancer perfusion embolization.
[1] 刘宗超，李哲轩，张阳，等.2020全球癌症统计报告解读[J].肿瘤综合治疗电子杂志，2021，7（2）：1-13.
[2] 杨薇，翟九玲.术中护理联合心理干预对肝癌介入栓塞术患者自我效能、不良情绪及护理满意度的影响[J].贵州医药，2021，45（9）：1493-1494.
[3] 周燕妮，陈晓蕾，皇甫淑娇，等.HFMEA在急诊外科危重患者院内安全转运管理中的应用[J].护理管理杂志，2021， 21（5）：375-378.
[4] 中国抗癌协会肝癌专业委员会，中华医学会肝病学分会肝癌学组，中国抗癌协会病理专业委员会，等.原发性肝癌规范化病理诊断指南（2015年版）[J].解放军医学杂志，2015，40（11）：865-872.
[5] Wong CK，Lam CL，Law WL，et al. Validity and reliability study on traditional Chinese FACT-C in Chinese patients with colorectal neoplasm [J]. J evaluation in clinical practice，2012，18（6）：1186-1195.
[6] 高超，王思花，王晓庆.癌因性疲乏病人运动障碍问卷的编制和信效度检测[J].全科护理，2016，14（17）：1741-1743.
[7] 潘宏铭，耿宝琴.肿瘤化疗的毒副反应和防治[M].上海：上海科学技术出版社，2001：35-40.
[8] Brayf，Ferlay J，Soerjomataram I，et al. Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin，2018，68（6）：394-424.
[9] 赵昌，马亦龙.血管介入治疗中、晚期肝癌的研究进展[J].广西医科大学学报，2021，38（5）：1060-1064.
[10] 蔡平凡，田文静，王莹，等.肝癌经动脉化疗栓塞术后急性腹痛预测模型构建[J].现代消化及介入诊疗，2021， 26（11）：1400-1403.
[11] 王汉萍.肝癌免疫检查点抑制剂治疗相关不良反应及处理[J].临床肝胆病杂志，2022，38（5）：985-991.
[12] 王斐斐，何婷，李炜，等.长链非编码RNA TPT1-AS1促进肝癌细胞增殖，迁移，侵袭的作用研究[J].疑难病杂志，2022，21（1）：24-30.
[13] 杨怀龙，钟唐力.DynaCT在原发性肝癌患者经肝动脉化疗栓塞术中的指导作用及对疗效的评估价值[J].临床肝胆病杂志，2022，38（4）：851-856.
[14] 程洋，蒲丛珊，郭辉，等.老年原发性肝癌介入术后患者癌症复发恐惧与应对方式的相关性[J].中国老年学杂志，2021，41（9）：1968-1971.
[15] 张增梅，孙立群，李胜云，等.医疗失效模式与效应分析法在乳腺癌保乳手术联合术中放疗安全管理中的应用[J].中华现代护理杂志，2019，25（13）：1693-1697.
[16] 曹青峰.螺旋CT灌注成像与超声造影在肝癌介入疗效及术后肿瘤活性评估中的应用[J].中国CT和MRI杂志，2021，19（2）：94-95，117.
[17] 艾宁，杨凯，王永中，等.经肝动脉灌注化疗栓塞术联合甲磺酸仑伐替尼在中晚期肝癌患者中的应用[J].中华实验外科杂志，2022，39（5）：938-940.
[18] 朱伟，陆美芹，倪杰，等.医疗失效模式与效应分析对肿瘤放疗患者医院感染的预防作用[J].医药高职教育与现代护理，2019，2（2）：114-117.
[19] 李冉，范会军，徐杰，等.超声造影、血清AFP、CEA水平对肝癌介入术后微血管侵犯、早期复发的预测价值[J].实用癌症杂志，2021，36（3）：452-456.
[20] 李建军，张志明.健脾化瘀方对脾虚血瘀型原发性肝癌患者AFP，CA19-9，CEA及KPS评分，QOL评分的影响[J].中国现代医生，2021，59（35）：9-12.
[21] 曹斗斗.数字减影血管造影技术在肝癌合并肝动脉-门静脉瘘介入治疗中的应用[J].当代医学，2021，27（20）：127-129.
京公网安备 11010502046598号